Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism

INTRODUCTION: Evocalcet is an oral calcimimetic agent with proven efficacy and safety in treating secondary hyperparathyroidism (SHPT) in Japanese patients on dialysis. METHODS: This randomized, double-blind, intrapatient dose-adjustment, parallel-group, international multicenter study compared the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Zhaohui, Liang, Xinling, Wu, Chia-Chao, Jin, Kyubok, Kim, Yong-Lim, Lu, Kuo-Cheng, Chan, Tak Mao, Fukagawa, Masafumi, Kinoshita, Jun, Nagai, Chisato, Kojima, Masahiro, Yu, Xueqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658267/
https://www.ncbi.nlm.nih.gov/pubmed/38025238
http://dx.doi.org/10.1016/j.ekir.2023.08.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658267/
https://www.ncbi.nlm.nih.gov/pubmed/38025238
http://dx.doi.org/10.1016/j.ekir.2023.08.034

Ejemplares similares